Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boots OTC divestiture

This article was originally published in The Tan Sheet

Executive Summary

Boots Group has provided a "memorandum of information" on its consumer unit, Boots Healthcare International, to parties who are "seriously interested" in purchasing the division, the firm said. The divestiture of the unit, which includes Clearasil skin care, Nurofen (ibuprofen) and Strepsils lozenges, is on track for completion by March 2006. Plans for the sale were announced in May (1"The Tan Sheet" May 30, 2005, p. 7)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098421

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel